Physician profile
John W Sperling
NPI 1881670776
$12,162,092.95
in general payments reported to CMS, 2019-2025
9 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584K · 2020: $597K · 2021: $894K · 2022: $1.8M · 2023: $6.2M · 2024: $852K · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7.2M · Consulting Fee: $533K · Education: $400K · Travel and Lodging: $111K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,249,398.78 |
| Consulting Fee | $533,370.00 |
| Education | $399,900.78 |
| Travel and Lodging | $110,644.94 |
| Food and Beverage | $13,375.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $11,952,636.01 | 2019-2025 | Comprehensive Shoulder System, Identity, Comprehensive Glenoid |
| Pacira Pharmaceuticals Incorporated | $97,976.51 | 2022-2025 | Exparel, Iovera, Zilretta |
| Medacta USA, INC. | $36,408.50 | 2024-2025 | Primary Shoulder, Mecta, Mypao |
| Responsive Arthroscopy INC | $35,464.20 | 2019-2025 | Responsive Arthroscopy Devices, Responsive Arthroscopy Medical Devices, Responsive Arthroscopy Devices |
| Exactech, INC. | $14,448.27 | 2019-2020 | |
| Medical Device Business Services, INC. | $14,019.93 | 2025 | Healix Knotless Peek |
| Pacira Therapeutics, INC. | $11,025.00 | 2021 | |
| Medartis INC. | $89.00 | 2023 | Aptus |
| Depuy Synthes Sales INC. | $25.53 | 2025 | Dynacord |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,910,383.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.